Form 4 for NTLA Intellia Therapeutics, Inc.
Accepted 2024-06-17 00:00:00 ET · period of report 2024-06-13 · accession 0000950170-24-074383 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-17 | 2024-06-13 | NTLA | Goff Brian | Dir | A - Grant | $0.00 | +15.4K | 15.4K | New | $0 |
| D | 2024-06-17 | 2024-06-13 | NTLA | Goff Brian | Dir | A - Grant | $0.00 | +22.3K | 22.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-13 | A | A | 15,409 | $0.00 | 15,409 | D | — | — | (F1) Based on a grant of restricted stock units representing a contingent right to receive one share of Intellia common stock for each restricted stock unit. |
| 2 | Derivative | Stock Option (right to buy) | 2024-06-13 | A | A | 22,297 | $0.00 | 22,297 | D | $25.96 · — to 2034-06-12 | 22,297 Common Stock | (F2) This option was granted on June 13, 2024 with respect to 22,297 shares of Common Stock pursuant to the Intellia Therapeutics, Inc. Amended and Restated 2015 Stock Option and Incentive Plan, with 33 1/3 % vesting on June 13, 2025 and the remaining 66 2/3% vesting in 8 substantially equal quarterly installments thereafter. |